asbestos lawyers - Worthington & Caron, PC

Over $2.5 billion

obtained for mesothelioma patients & families

MARF News

January 24, 1999 Roger G. Worthington Maui, Hawaii Today, in a small town somewhere in America, a 60 year old man will be told by his doctor that he has malignant mesothelioma. His doctor, after looking the word up in an old medical textbook, will tell him that the tumor is "incurable". ...
Help is on the way! Senator Patty Murray announced today (June 18, 2002) the Ban Asbestos In America Act, a bill which will finally outlaw asbestos products in the US and, among other things, authorize the creation of a national mesothelioma registry, as well as allocate $3.5 million annually for 4 ...
In July of 2001, the Mesothelioma Applied Research Foundation (MARF) sent the letter below, signed by this country's leading experts in the treatment of malignant mesothelioma, to over 700 asbestos trial lawyers. MARF is urging attorneys to expand their role as an advocate by helping MARF meet ...
As I write this, the Mesothelioma Applied Research Foundation, Inc., a 501(c)(3) charity, is advocating on Capitol Hill for the creation of a Mesothelioma Research and Treatment Program within the Department of Defense and/or the Department of Veterans Affairs. We are presently drafting language for ...
The Washington Post < http://www.washingtonpost.com/wp-dyn/articles/A35425-2003Apr24.html > and the New York Times, are reporting that asbestos companies and their insurers, plaintiffs' lawyers, unions and key U.S. senators may be close to agreement on establishing a $100 billion trust ...
Board of Directors Robert B. Cameron, M.D. UCLA Medical SchoolNicholas J. Vogelzang, M.D. Nevada Cancer Institute Brian Loggie, M.D. Creighton University Medical Center Michael Harbut, M.D., M.P.H. Royal Oak, MI Roger G. Worthington, Esq. Dallas, Texas Mathew Bergman, Esq. Seattle, Washington Susan ...
Michele Carbone, MD, PhD; Hedy Lee Kindler, MD; Valerie Rusch, MD. (Transcribed from MARF Executive Director Chris Hahn's notes of a presentation made at ASCO, May 19, 2002.) * * * * * * * * * * * * Pathology and Genetics of Mesothelioma. Michele Carbone, MD, PhD Pathology Dr. Carbone first ...
Board of Directors M. Ann Abbe Arlington, Texas Mathew Bergman, Esq. Seattle, Washington Robert B. Cameron, M.D. UCLA Medical School Michael Harbut, M.D., M.P.H. Wayne State University Ulf Jungnelius, M.D. Pfizer, Inc. Susan Vento St. Paul, Minnesota Nicholas J. Vogelzang, M.D. Nevada Cancer ...
Board of Directors Robert B. Cameron, M.D. UCLA Medical School Nicholas J. Vogelzang, M.D. University of Chicago M. Ann Abbe Arlington, Texas Michael Harbut, M.D., M.P.H. Royal Oak, MI Roger G. Worthington, Esq. Dallas, Texas Matthew Bergman, Esq. Seattle, Washington Susan Vento St. Paul, Minnesota ...
Board of Directors Robert B. Cameron, M.D. UCLA Medical School Nicholas J. Vogelzang, M.D. University of Chicago Brian Loggie, M.D. Creighton University Medical Center Michael Harbut, M.D., M.P.H. Royal Oak, Michigan Roger G. Worthington, Esq. Dallas, Texas Mathew Bergman, Esq. Seattle, Washington ...

Get Empowered

We put your medical and personal needs first and provide compassionate representation.

Speak with an Attorney